Foyston, Gordon, & Payne Inc - Q1 2015 holdings

$677 Million is the total value of Foyston, Gordon, & Payne Inc's 71 reported holdings in Q1 2015. The portfolio turnover from Q4 2014 to Q1 2015 was 8.0% .

 Value Shares↓ Weighting
TEVA BuyTeva Pharmaceutical - ADR$39,658,000
+89.6%
636,573
+1.7%
5.85%
+95.9%
MDT NewMedtronic Inc.$37,310,000478,391
+100.0%
5.51%
VZ BuyVerizon Communications Inc.$24,069,000
+4.0%
494,942
+0.1%
3.55%
+7.5%
WBA NewWalgreens Boots Alliance Inc.$23,959,000282,939
+100.0%
3.54%
MSFT BuyMicrosoft Corp.$22,908,000
-2.2%
563,470
+11.7%
3.38%
+1.0%
APA BuyApache Corp.$19,684,000
+10.4%
326,276
+14.7%
2.91%
+14.1%
PFE BuyPfizer Inc.$19,170,000
+14.1%
551,014
+2.2%
2.83%
+18.0%
JCI BuyJohnson Controls Inc.$18,043,000
+19.1%
357,705
+14.2%
2.66%
+23.1%
JNJ BuyJohnson & Johnson$18,038,000
+13.6%
179,304
+18.1%
2.66%
+17.4%
FCX BuyFreeport-McMoRan Copper & Gold Inc.$16,187,000
-4.9%
854,177
+17.2%
2.39%
-1.8%
ICL BuyIsrael Chemicals Ltd.$12,369,000
+0.1%
1,744,557
+2.4%
1.83%
+3.5%
TDW BuyTidewater Inc.$11,438,000
-19.9%
597,610
+35.6%
1.69%
-17.3%
MAT BuyMattel Inc.$10,640,000
-25.9%
465,649
+0.4%
1.57%
-23.4%
HWC BuyHancock Holding Co.$10,127,000
+27.8%
339,153
+31.4%
1.50%
+32.1%
ANF BuyAbercombie & Fitch Co. Cl A$9,330,000
-18.6%
423,311
+5.8%
1.38%
-15.8%
CSX BuyCSX Corporation$9,227,000
+14.7%
278,601
+25.4%
1.36%
+18.5%
KT BuyKT Corp. - ADR$8,291,000
+9.3%
633,857
+18.0%
1.22%
+12.9%
KN BuyKnowles Corp.$8,050,000
-9.7%
417,738
+10.4%
1.19%
-6.7%
PTR BuyPetrochina Co. Ltd. - ADR$6,268,000
+7.1%
56,365
+6.8%
0.92%
+10.6%
CCU BuyCia Cervecerias Unidas - ADR$5,543,000
+16.3%
266,989
+3.9%
0.82%
+20.1%
RDSA BuyRoyal Dutch Shell PLC ADR A$4,061,000
-1.1%
68,086
+11.0%
0.60%
+2.0%
SSL BuySasol Ltd. - ADR$1,144,000
+26.5%
33,609
+41.2%
0.17%
+31.0%
CHL BuyChina Mobile HK Ltd. - ADR$746,000
+22.3%
11,473
+10.6%
0.11%
+26.4%
ABBV BuyAbbVie Inc.$717,000
-10.2%
12,240
+0.3%
0.11%
-7.0%
VIV BuyTelefonica Brasil SA - ADR$653,000
-4.8%
42,737
+10.1%
0.10%
-2.0%
UTX BuyUnited Technologies Corp.$610,000
+2.3%
5,205
+0.4%
0.09%
+5.9%
ABT BuyAbbott Laboratories$569,000
+3.6%
12,275
+0.6%
0.08%
+7.7%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR/A filed 2015-05-15
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Microsoft Corp.42Q3 202310.2%
Johnson & Johnson42Q3 20239.3%
Mondelez International Inc.42Q3 20234.0%
Coca Cola Co.42Q3 20231.7%
Berkshire Hathaway Inc. CL B42Q3 20231.6%
Becton Dickinson & Co.42Q3 20232.7%
Wal-Mart Stores Inc.42Q3 20230.9%
AbbVie Inc.42Q3 20230.5%
Abbott Laboratories42Q3 20230.4%
Procter & Gamble Co.42Q3 20230.2%

View Foyston, Gordon, & Payne Inc's complete holdings history.

Latest significant ownerships (13-D/G)
Foyston, Gordon, & Payne Inc Q1 2015 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Foyston, Gordon, & Payne IncSeptember 20, 20124,798,3874.8%
Foyston, Gordon, & Payne IncApril 25, 20128,966,3829.2%
TECUMSEH PRODUCTS COJuly 17, 2006553,5794.1%
CPI CORPSold outApril 27, 200600.0%

View Foyston, Gordon, & Payne Inc's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-07
13F-HR2024-02-07
13F-HR2023-10-26
13F-HR2023-08-01
13F-HR2023-05-03
13F-HR2023-02-09
13F-HR2022-11-04
13F-HR2022-08-11
13F-HR2022-04-27
13F-HR2022-02-11

View Foyston, Gordon, & Payne Inc's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported has been restated
  • The reported has been amended

Export Foyston, Gordon, & Payne Inc's holdings